Laura Brege - Director at Mirum Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
MIRM on Nasdaq
All Insider Reports
All Insider Reports

Laura Brege - trading volume in the past year for Mirum Pharmaceuticals, Inc.

Holdings reported by Laura Brege for Mirum Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 15,703 $1,178,824 $75.07 11 Sep 2025 Direct
Restricted Stock Units 0 $146,453 $25.68 29 May 2025 Direct Common Stock
Deferred Stock Units 3,977 29 May 2025 Direct Common Stock
Stock Option (right to buy) 0 11 Sep 2025 Direct Common Stock

Transactions reported by Laura Brege for Mirum Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.